Cerium Pharmaceuticals
Cerium Pharmaceuticals is dedicated to creating efficacious therapies for patients with kidney diseases. Cerium is currently focused on developing the first drug approved for a very rare kidney disease called Primary Membranous Nephropathy (PMN). There are approximately PMN patients in the US and approximately newly diagnosed PMN patients per year.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
2
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Cerium Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- GL
Gregg Lapointe
-, · Other
EmailPhone - NK
Nancy Klett
Chief Operating Officer · General Business & Management
EmailPhone - TD
Thomas Depasquale
Chairperson · General Business & Management
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Cerium Pharmaceuticals
4 distinct titles indexed · top 4 shown.
- 1-,
- 1chairperson
- 1chief operating officer
- 1chief scientific officer
Sign up to unlock all 4 contacts at Cerium Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Cerium Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.